Prostate cancer (PCa) prognosis and clinical outcome is directly dependent on metastatic occurrence. The bone microenvironment is a favorable metastatic niche. Different biological processes have been suggested to contribute to the osteotropism of PCa such as hemodynamics, bone-specific signaling interactions, and the "seed and soil" hypothesis. However, prevalence of disseminating tumor cells in the bone is not proportional to the actual occurrence of metastases, as not all patients will develop bone metastases. The fate and tumor-reforming ability of a metastatic cell is greatly influenced by the microenvironment. In this review, the molecular mechanisms of bone and soft-tissue metastasis in PCa are discussed. Specific attention is dedica...
The majority of men with progressive prostate cancer develop metastases with the skeleton being the ...
The bone is a common site for metastasis in patients with advanced prostate carcinoma, and provides ...
Bone metastasis is the most devastating and untreatable complication associated with prostate cancer...
Advanced-stage prostate cancer (PCa) patients are often diagnosed with bone metastases. Bone metasta...
The onset of metastases dramatically changes the prognosis of prostate cancer patients, determining ...
The interplay in prostate cancer bone metastases between the 'seed' (the prostate cancer cells) and ...
Bone is the most common site for metastasis in human prostate cancer patients. Skeletal metastases a...
Patients with advanced prostate cancer often develop bone metastases, leading to bone pain, skeletal...
Most of the prostate cancers (PCa) in advanced stage will progress to castration-resistant prostate ...
Prostate cancer metastasis to the bone occurs at high frequency in patients with advanced disease, c...
protein, stromal-derived factor, matrix metalloproteinase The majority of men with progressive prost...
This article describes cell signaling network of metastatic prostate cancer (PCa) to bone and viscer...
Bone is one of the most preferential target site for cancer metastases, particularly for prostate, b...
Prostate cancer (PC) is one of the most common cancers arising in men and has a high propensity for ...
Owing to its frequent occurrence and severe clinical picture, bone metastasis is an important proble...
The majority of men with progressive prostate cancer develop metastases with the skeleton being the ...
The bone is a common site for metastasis in patients with advanced prostate carcinoma, and provides ...
Bone metastasis is the most devastating and untreatable complication associated with prostate cancer...
Advanced-stage prostate cancer (PCa) patients are often diagnosed with bone metastases. Bone metasta...
The onset of metastases dramatically changes the prognosis of prostate cancer patients, determining ...
The interplay in prostate cancer bone metastases between the 'seed' (the prostate cancer cells) and ...
Bone is the most common site for metastasis in human prostate cancer patients. Skeletal metastases a...
Patients with advanced prostate cancer often develop bone metastases, leading to bone pain, skeletal...
Most of the prostate cancers (PCa) in advanced stage will progress to castration-resistant prostate ...
Prostate cancer metastasis to the bone occurs at high frequency in patients with advanced disease, c...
protein, stromal-derived factor, matrix metalloproteinase The majority of men with progressive prost...
This article describes cell signaling network of metastatic prostate cancer (PCa) to bone and viscer...
Bone is one of the most preferential target site for cancer metastases, particularly for prostate, b...
Prostate cancer (PC) is one of the most common cancers arising in men and has a high propensity for ...
Owing to its frequent occurrence and severe clinical picture, bone metastasis is an important proble...
The majority of men with progressive prostate cancer develop metastases with the skeleton being the ...
The bone is a common site for metastasis in patients with advanced prostate carcinoma, and provides ...
Bone metastasis is the most devastating and untreatable complication associated with prostate cancer...